Dow Down 1.29% Nasdaq Down 3.25%

Amicus Therapeutics, Inc. (FOLD)

-NasdaqGM
5.99 Down 0.41(6.41%) 4:00PM EST
Prev Close:6.40
Open:6.37
Bid:4.68 x 200
Ask:6.88 x 300
1y Target Est:14.00
Beta:0.985818
Earnings Date:Mar 1 - Mar 7 (Est.)
Day's Range:5.84 - 6.37
52wk Range:5.64 - 18.83
Volume:2,119,931
Avg Vol (3m):2,095,700
Market Cap:748.91M
P/E (ttm):N/A
EPS (ttm):-1.10
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for FOLD

Comparison

Symbol% ChgMkt Cap
FOLDDown 6.41%748.91M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.15
Quarterly EPS Est (Dec-15) :-0.31
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Amicus Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapeutic products for rare and orphan diseases. Its product candidate is a small molecule that can be used as a monotherapy and in combination with enzyme repla... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback